Motivations for inadequate persistence with disease modifying anti-rheumatic drugs in early rheumatoid arthritis: the patient’s perspective

Documenti analoghi

• Window of opportunity to achieve major outcomes in early rheumatoid arthritis patients: how persistence with therapy matters
  di: Contreras-Yáñez, Irazú, et al.
  Pubblicazione: (2015)
• Patient’s perspective of sustained remission in rheumatoid arthritis
  di: Irazú Contreras-Yáñez, et al.
  Pubblicazione: (2017-09-01)
• Patient’s perspective of sustained remission in rheumatoid arthritis
  di: Contreras-Yáñez, Irazú, et al.
  Pubblicazione: (2017)
• Predictors of health care drop-out in an inception cohort of patients with early onset rheumatoid arthritis
  di: Contreras-Yáñez, Irazú, et al.
  Pubblicazione: (2017)
• Prevalence, incidence and characteristics of the metabolic syndrome (MetS) in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease modifying anti-rheumatic drugs: the complex relationship between MetS and disease activity
  di: Parra-Salcedo, Federico, et al.
  Pubblicazione: (2015)